Community acquired pneumonia caused by Streptococcus Pneumoniae, Haemophilus Influenzae, Methicillin-Sensitive Staphylococcus Aureus Infection, Legionella Pneumophila Infections, Mycoplasma pneumoniae infection, Chlamydophila Pneumoniae Infections
Drug | Drug Name | Drug Description |
---|---|---|
DB12825 | Lefamulin | A pleuromutilin antibacterial used to treat community-acquired bacterial pneumonia (CABP). |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB12825 | Lefamulin | Cytochrome P450 3A4 | enzyme |
DB12825 | Lefamulin | 50S ribosomal protein L22 | target |
DB12825 | Lefamulin | P-glycoprotein 1 | transporter |
Drug | Drug Name | Phase | Status | Count |
---|